Detalhe da pesquisa
1.
The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation.
Nephrol Dial Transplant
; 36(1): 160-169, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33068419
2.
Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients.
Nephrol Dial Transplant
; 33(7): 1207-1214, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28992343
3.
Serum Potassium and Short-term Clinical Outcomes Among Hemodialysis Patients: Impact of the Long Interdialytic Interval.
Am J Kidney Dis
; 70(1): 21-29, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28111027
4.
Patiromer Lowers Serum Potassium When Taken without Food: Comparison to Dosing with Food from an Open-Label, Randomized, Parallel Group Hyperkalemia Study.
Am J Nephrol
; 46(4): 323-332, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29017162
5.
Calcium Balance in Chronic Kidney Disease.
Curr Osteoporos Rep
; 15(3): 214-221, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28474258
6.
Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.
JAMA
; 317(2): 146-155, 2017 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28097355
7.
Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis.
Am J Nephrol
; 44(5): 404-410, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27784004
8.
Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism.
Kidney Int
; 87(4): 846-56, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25337774
9.
Treatment of Secondary Hyperparathyroidism: Results of a Phase 2 Trial Evaluating an Intravenous Peptide Agonist of the Calcium-Sensing Receptor.
Am J Nephrol
; 42(5): 379-88, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26684933
10.
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
Kidney360
; 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38323855
11.
Effects of phosphate binders in moderate CKD.
J Am Soc Nephrol
; 23(8): 1407-15, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22822075
12.
Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets.
Kidney Int
; 81(11): 1116-22, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22297674
13.
A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR).
Semin Thromb Hemost
; 38(8): 783-96, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23111861
14.
Outpatient red blood cell transfusion payments among patients on chronic dialysis.
BMC Nephrol
; 13: 145, 2012 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23121762
15.
Magnesium in chronic kidney disease: unanswered questions.
Blood Purif
; 31(1-3): 172-6, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21228586
16.
Changes in hemoglobin level distribution in US dialysis patients from June 2006 to November 2008.
Am J Kidney Dis
; 55(1): 113-20, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19932539
17.
Psychometric evaluation of the National Kidney Dialysis and Kidney Transplantation Study symptom checklist: reliability and validity.
Nephrol Dial Transplant
; 24(2): 619-25, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18799605
18.
How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?
J Nephrol
; 22(2): 255-62, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19384844
19.
Hemoglobin variability in chronic kidney disease: a cross-sectional study.
Am J Med Sci
; 337(5): 340-3, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19295412
20.
Interpreting observational studies of disordered mineral metabolism and mortality in patients on hemodialysis.
Nat Clin Pract Nephrol
; 5(1): 16-7, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19002135